Guardado en:
| Autores principales: | Dowd, Nathaniel P., Blette, Bryan, Chappell, James D., Halasa, Natasha B., Spieker, Andrew J. |
|---|---|
| Formato: | Preprint |
| Publicado: |
2024
|
| Materias: | |
| Acceso en línea: | https://arxiv.org/abs/2407.21253 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
A prospective humoral immune monitoring study of kidney transplant recipients receiving three doses of SARS‐CoV‐2 mRNA vaccine
por: Cinzia Borgogna, et al.
Publicado: (2024)
por: Cinzia Borgogna, et al.
Publicado: (2024)
Anti‐spike antibody durability after SARS‐CoV‐2 vaccination in adolescent solid organ transplant recipients
por: John McAteer, et al.
Publicado: (2024)
por: John McAteer, et al.
Publicado: (2024)
Cellular and humoral response after mRNA SARS‐CoV‐2 vaccination in kidney transplant recipients living with HIV: A cross‐sectional study
por: Judit Cacho, et al.
Publicado: (2025)
por: Judit Cacho, et al.
Publicado: (2025)
Current management of SARS‐CoV‐2 infection in solid organ transplant recipients: Experience derived from an ESGICH–ESOT survey
por: Alessandro Visentin, et al.
Publicado: (2024)
por: Alessandro Visentin, et al.
Publicado: (2024)
Chromomycosis in solid organ transplant recipients
por: Isadora Zago Miotto, et al.
Publicado: (2024)
por: Isadora Zago Miotto, et al.
Publicado: (2024)
Blood donor SARS‐CoV‐2 infection or vaccination and adverse outcomes in plasma and platelet transfusion recipients
por: Nareg H. Roubinian, et al.
Publicado: (2025)
por: Nareg H. Roubinian, et al.
Publicado: (2025)
Rice‐derived SARS‐CoV‐2 glycoprotein S1 subunit vaccine elicits humoral and cellular immune responses
por: Li Song, et al.
Publicado: (2025)
por: Li Song, et al.
Publicado: (2025)
Safety of anidulafungin in solid organ transplant recipients
por: Aguado, J.M., et al.
Publicado: (2012)
por: Aguado, J.M., et al.
Publicado: (2012)
A role for extensive SARS‐CoV‐2 virological assessment of donor and recipient in lung transplantation
por: Jan Van Slambrouck, et al.
Publicado: (2024)
por: Jan Van Slambrouck, et al.
Publicado: (2024)
Outcomes in solid organ transplant recipients receiving organs from a donor with Fusarium solani species complex meningitis
por: Isabel S. Griffin, et al.
Publicado: (2024)
por: Isabel S. Griffin, et al.
Publicado: (2024)
Use of biologics for psoriasis in solid organ transplant recipients
por: Marta Costa Blasco, et al.
Publicado: (2024)
por: Marta Costa Blasco, et al.
Publicado: (2024)
PLGA‐particle‐based vaccine induces SARS‐CoV‐2‐specific antibody and T‐cell responses
por: Dennis Horvath, et al.
Publicado: (2026)
por: Dennis Horvath, et al.
Publicado: (2026)
Prolonged SARS‐CoV‐2 shedding in a lung transplant recipient: time for flexibility in infection prevention?
por: Alyssa Pradhan, et al.
Publicado: (2024)
por: Alyssa Pradhan, et al.
Publicado: (2024)
Serological response to SARS‐CoV‐2 vaccination in patients with immunobullous diseases
por: B. Levian, et al.
Publicado: (2024)
por: B. Levian, et al.
Publicado: (2024)
Incidence of biliary atresia in the United States before and during the COVID‐19 pandemic
por: Yasmeen Z. Qwaider, et al.
Publicado: (2025)
por: Yasmeen Z. Qwaider, et al.
Publicado: (2025)
Clinical outcomes of SARS‐CoV‐2 infection in kidney transplant recipients on belatacept: a single‐center experience
por: Fionna Feller, et al.
Publicado: (2024)
por: Fionna Feller, et al.
Publicado: (2024)
Humoral epitope dominance and immune imprinting by SARS ‐ CoV ‐1 and SARS ‐ CoV ‐2 vaccines
por: Deborah L Burnett, et al.
Publicado: (2026)
por: Deborah L Burnett, et al.
Publicado: (2026)
Effect of Bacille Calmette–Guérin vaccination on immune responses to SARS‐CoV‐2 and COVID‐19 vaccination
por: Nicole L Messina, et al.
Publicado: (2025)
por: Nicole L Messina, et al.
Publicado: (2025)
Letter to the editor: Poor sensitivity of anti‐nucleocapsid antibody in detecting prior COVID‐19 in vaccinated solid organ transplant recipients
por: Jennifer L. Alejo, et al.
Publicado: (2024)
por: Jennifer L. Alejo, et al.
Publicado: (2024)
Tixagevimab/cilgavimab for the prevention of COVID‐19 in solid organ transplant recipients
por: Emily Eribes, et al.
Publicado: (2024)
por: Emily Eribes, et al.
Publicado: (2024)
Sex differences in cancer mortality among solid organ transplant recipients
por: Sarah S. Jackson, et al.
Publicado: (2025)
por: Sarah S. Jackson, et al.
Publicado: (2025)
Safety and immunogenicity of vaccines against SARS-CoV-2
por: Francisco Xavier Poveda Paredes
Publicado: (2021)
por: Francisco Xavier Poveda Paredes
Publicado: (2021)
Monte Carlo simulation of SARS-CoV-2 radiation-induced inactivation for vaccine development
por: Francis, Ziad, et al.
Publicado: (2020)
por: Francis, Ziad, et al.
Publicado: (2020)
Biological characteristics of SARS-CoV-2 variants of epidemiological interest and their impact on vaccine efficacy and effectiveness.
por: Torres, Carolina, et al.
Publicado: (2021)
por: Torres, Carolina, et al.
Publicado: (2021)
Comparable CD8+ T‐cell responses to SARS‐CoV‐2 vaccination in single‐cell transcriptomics of recently allogeneic transplanted patients and healthy individuals
por: Eva Tranter, et al.
Publicado: (2024)
por: Eva Tranter, et al.
Publicado: (2024)
Transfusion requirements in recipients of plasma units from blood donors with recent SARS ‐ CoV ‐2 infection
por: Nareg H. Roubinian, et al.
Publicado: (2026)
por: Nareg H. Roubinian, et al.
Publicado: (2026)
What is best practice for the prevention of anti‐D alloimmunisation in D‐negative recipients receiving solid organ transplants from D‐positive donors
por: Thomas Lynes, et al.
Publicado: (2024)
por: Thomas Lynes, et al.
Publicado: (2024)
An improvement of the safety profile of SARS‐CoV‐2 vaccines is desirable
por: Josef Finsterer
Publicado: (2024)
por: Josef Finsterer
Publicado: (2024)
The characteristics of BCR‐CDR3 repertoire in COVID‐19 patients and SARS‐CoV‐2 vaccinated volunteers
por: Jiaping Xiao, et al.
Publicado: (2024)
por: Jiaping Xiao, et al.
Publicado: (2024)
Recombinant zoster vaccine induces superior immunogenicity compared with live varicella vaccine in allogeneic haematopoietic stem cell transplantation recipients
por: Takaaki Ono, et al.
Publicado: (2026)
por: Takaaki Ono, et al.
Publicado: (2026)
Cumulative exposure to tacrolimus is associated with increased risk of malignancy for solid organ transplant recipients
por: Sergio A. Acuna, et al.
Publicado: (2026)
por: Sergio A. Acuna, et al.
Publicado: (2026)
Pediatric solid organ transplant recipients positive for severe acute respiratory syndrome coronavirus 2 pre‐transplant
por: Taylor Heald‐Sargent, et al.
Publicado: (2024)
por: Taylor Heald‐Sargent, et al.
Publicado: (2024)
The impact of B‐cell reconstitution on mRNA vaccine responses in allogeneic stem cell transplant recipients
por: Fredrika Hellgren, et al.
Publicado: (2026)
por: Fredrika Hellgren, et al.
Publicado: (2026)
Clinical overview for pediatric population with SARS-CoV-2 and care: review
por: Martins, Lucas Amaral, et al.
Publicado: (2021)
por: Martins, Lucas Amaral, et al.
Publicado: (2021)
Humoral and cellular immune responses in vaccinated and unvaccinated children following SARS‐CoV‐2 Omicron infection
por: Zheng Quan Toh, et al.
Publicado: (2024)
por: Zheng Quan Toh, et al.
Publicado: (2024)
Combining SARS‐CoV‐2 interferon‐gamma release assay with humoral response assessment to define immune memory profiles
por: William Mouton, et al.
Publicado: (2024)
por: William Mouton, et al.
Publicado: (2024)
Managing the significant drug‐drug interaction between isavuconazole and tacrolimus in solid organ transplant recipients
por: Jessica Hedvat, et al.
Publicado: (2024)
por: Jessica Hedvat, et al.
Publicado: (2024)
Malignancy following solid organ transplantation: Current techniques for determination of donor versus recipient origin
por: Rebecca Rojansky, et al.
Publicado: (2024)
por: Rebecca Rojansky, et al.
Publicado: (2024)
Advancing cytomegalovirus prevention in solid organ transplant recipients: The promise of cell‐mediated immune assays
por: Vivek B. Beechar, et al.
Publicado: (2024)
por: Vivek B. Beechar, et al.
Publicado: (2024)
Humoral immune response and safety of SARS‐CoV‐2 vaccination in very early onset inflammatory bowel disease
por: Arthur J. Kastl, et al.
Publicado: (2024)
por: Arthur J. Kastl, et al.
Publicado: (2024)
Ejemplares similares
-
A prospective humoral immune monitoring study of kidney transplant recipients receiving three doses of SARS‐CoV‐2 mRNA vaccine
por: Cinzia Borgogna, et al.
Publicado: (2024) -
Anti‐spike antibody durability after SARS‐CoV‐2 vaccination in adolescent solid organ transplant recipients
por: John McAteer, et al.
Publicado: (2024) -
Cellular and humoral response after mRNA SARS‐CoV‐2 vaccination in kidney transplant recipients living with HIV: A cross‐sectional study
por: Judit Cacho, et al.
Publicado: (2025) -
Current management of SARS‐CoV‐2 infection in solid organ transplant recipients: Experience derived from an ESGICH–ESOT survey
por: Alessandro Visentin, et al.
Publicado: (2024) -
Chromomycosis in solid organ transplant recipients
por: Isadora Zago Miotto, et al.
Publicado: (2024)